Global Contraceptive Devices Market to Reach US$ 19.0 Billion by 2028, Propelled by Rising Incidences of Unintended Pregnancies

July 28, 2023 | Healthcare

The latest report by IMARC Group, titled “Contraceptive Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2023-2028,” finds that the global contraceptive devices market size reached US$ 13.5 Billion in 2022. Contraceptive devices are tools or products designed to prevent pregnancy by either blocking the fertilization of an egg or creating a barrier between sperm and the egg. They offer individuals and couples numerous options for family planning and allow them to make informed choices about their reproductive health. There are various types of contraceptive devices available, such as female and male condoms, diaphragms, and cervical caps, which physically prevent sperm from reaching the egg and create a barrier that blocks the entry of sperm into the uterus. Hormonal methods use synthetic hormones to regulate a woman's menstrual cycle and prevent ovulation, such as birth control pills, contraceptive patches, vaginal rings, and contraceptive injections that release hormones that repress ovulation and thicken cervical mucus, making it difficult for sperm to reach the egg. Nowadays, contraceptive devices offer individuals and couples flexibility in choosing a method that suits their needs and lifestyle.

Global Contraceptive Devices Market Trends:

The contraceptive devices market is primarily driven by the rising incidences of unintended pregnancies. Additionally, the increasing population and the subsequent rise in the demand for effective and reliable birth control methods are contributing to market growth. Also, the escalating demand for contraceptive devices and products designed to prevent pregnancy by inhibiting or controlling the reproductive process is influencing market growth. Moreover, with the growing awareness regarding the importance of family planning and the need for population control, individuals and couples are actively seeking contraceptive solutions to exercise control over their reproductive choices representing another major growth-inducing factor. Besides this, numerous advancements in contraceptive technology and the development of more convenient, efficient, and user-friendly contraceptive devices are accelerating the product adoption rate. Along with this, key players are investing in research and development (R&D) to introduce novel contraceptive solutions that offer improved efficacy, safety, and ease of use, propelling the market growth. In addition, the development of long-acting reversible contraceptives (LARCs), such as hormonal implants and intrauterine devices (IUDs), provides extended protection and minimizes the need for frequent intervention, and the integration of smart technologies and digital applications into contraceptive devices is also gaining traction, allowing better monitoring and control of contraception, propelling the market growth. Furthermore, several governments and healthcare organizations are implementing initiatives to promote family planning and make contraceptive devices more accessible and affordable, creating a positive market outlook. Looking forward, IMARC Group expects the market value to reach US$ 19.0 Billion by 2028, exhibiting a CAGR of 5.3% during the forecast period (2023-2028).

Market Summary:

Based on the device type, the market has been divided into condoms, diaphragms, cervical caps, sponges, vaginal rings, IUDs, and others. Condoms currently represent the most popular device type.
On the basis of end user, the market has been bifurcated into male and female, wherein male exhibit a clear dominance in the market.
Based on the distribution channel, the market has been classified into hospital pharmacies, retail pharmacies, online stores, and others. Amongst these, retail pharmacies accounts for the largest market share.
Region-wise, the market has been segregated into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Latin America (Brazil, Mexico and others), and Middle East and Africa. North America holds the leading position in the market.
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players. Some of these players include Allergan plc, Bayer AG, Church & Dwight Co., Inc., CooperSurgical Inc., Merck & Co., Mylan Inc., Pfizer Inc., Reckitt Benckiser Group plc, Teva Pharmaceutical Industries Ltd., and The Female Health Company.

Report Scope:

Report Features	Details
Base Year of the Analysis	2022
Historical Period	2017-2022
Forecast Period	2023-2028
Units	US$ Billion
Segment Coverage	Device Type, End User, Distribution Channel, Region
Region Covered	Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered	United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered	Allergan plc, Bayer AG, Church & Dwight Co., Inc., CooperSurgical Inc., Merck & Co., Mylan Inc., Pfizer Inc., Reckitt Benckiser Group plc, Teva Pharmaceutical Industries Ltd., and The Female Health Company
Customization Scope	10% Free Customization
Report Price and Purchase Option	Single User License: US$ 2499 Five User License: US$ 3499 Corporate License: US$ 4499
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Global Contraceptive Devices Market to Reach US$ 19.0 Billion by 2028, Propelled by Rising Incidences of Unintended Pregnancies

Purchase options Year End sale

Single User License ~~$2499~~ $2249
Five User License ~~$3499~~ $2974
Corporate License ~~$4499~~ $3599

Inquire Before Buying

Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Speak to an Analyst

Request Brochure

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.